{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:44:54Z","timestamp":1793839494673,"version":"4.6.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41380-018-0076-7","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T11:12:33Z","timestamp":1531134753000},"page":"1523-1532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":194,"title":["Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice"],"prefix":"10.1038","volume":"24","author":[{"given":"Adam K.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Wing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dantzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"key":"76_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012;13:465\u201377.","journal-title":"Nat Rev Neurosci"},{"key":"76_CR2","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/npp.2013.71","volume":"38","author":"AK Walker","year":"2013","unstructured":"Walker AK, Budac DP, Bisulco S, Lee AW, Smith RA, Beenders B, et al. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice. Neuropsychopharmacology. 2013;38:1609\u201316.","journal-title":"Neuropsychopharmacology"},{"key":"76_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","volume":"22","author":"S Bonaccorso","year":"2002","unstructured":"Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, et al. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol. 2002;22:86\u201390.","journal-title":"J Clin Psychopharmacol"},{"key":"76_CR4","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","volume":"54","author":"L Capuron","year":"2003","unstructured":"Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, et al. Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry. 2003;54:906\u201314.","journal-title":"Biol Psychiatry"},{"key":"76_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/sj.mp.4000872","volume":"6","author":"M Maes","year":"2001","unstructured":"Maes M, Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, et al. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation. Mol Psychiatry. 2001;6:475\u201380.","journal-title":"Mol Psychiatry"},{"key":"76_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry. 2010;15:393\u2013403.","journal-title":"Mol Psychiatry"},{"key":"76_CR7","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.4049\/jimmunol.0802722","volume":"182","author":"JC O\u2019Connor","year":"2009","unstructured":"O\u2019Connor JC, Lawson MA, Andre C, Briley EM, Szegedi SS, Lestage J, et al. Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol. 2009;182:3202\u201312.","journal-title":"J Immunol"},{"key":"76_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O\u2019Connor","year":"2009","unstructured":"O\u2019Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry. 2009;14:511\u201322.","journal-title":"Mol Psychiatry"},{"key":"76_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.200","volume":"6","author":"JM Parrott","year":"2016","unstructured":"Parrott JM, Redus L, Santana-Coelho D, Morales J, Gao X, O\u2019Connor JC. Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation. Transl Psychiatry. 2016;6:e918.","journal-title":"Transl Psychiatry"},{"key":"76_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1046\/j.1471-4159.2002.00955.x","volume":"82","author":"T Kita","year":"2002","unstructured":"Kita T, Morrison PF, Heyes MP, Markey SP. Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain. J Neurochem. 2002;82:258\u201368.","journal-title":"J Neurochem"},{"key":"76_CR11","doi-asserted-by":"publisher","first-page":"12079","DOI":"10.1073\/pnas.96.21.12079","volume":"96","author":"RJ Boado","year":"1999","unstructured":"Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci USA. 1999;96:12079\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"76_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/cbf.1455","volume":"26","author":"Y Omidi","year":"2008","unstructured":"Omidi Y, Barar J, Ahmadian S, Heidari HR, Gumbleton M. Characterization and astrocytic modulation of system L transporters in brain microvasculature endothelial cells. Cell Biochem Funct. 2008;26:381\u201391.","journal-title":"Cell Biochem Funct"},{"key":"76_CR13","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1523\/JNEUROSCI.5032-08.2009","volume":"29","author":"JC O\u2019Connor","year":"2009","unstructured":"O\u2019Connor JC, Andre C, Wang Y, Lawson MA, Szegedi SS, Lestage J, et al. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci. 2009;29:4200\u20139.","journal-title":"J Neurosci"},{"key":"76_CR14","doi-asserted-by":"publisher","first-page":"e0170346","DOI":"10.1371\/journal.pone.0170346","volume":"12","author":"Y Ni","year":"2017","unstructured":"Ni Y, Teng T, Li R, Simonyi A, Sun GY, Lee JC. TNF\u03b1 alters occludin and cerebral endothelial permeability: Role of p38MAPK. PLoS ONE. 2017;12:e0170346.","journal-title":"PLoS ONE"},{"key":"76_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-0826-9","volume":"4","author":"A Sekine","year":"2015","unstructured":"Sekine A, Okamoto M, Kanatani Y, Sano M, Shibata K, Fukuwatari T. Amino acids inhibit kynurenic acid formation via suppression of kynurenine uptake or kynurenic acid synthesis in rat brain in vitro. Springerplus. 2015;4:48.","journal-title":"Springerplus"},{"key":"76_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.fsi.2016.03.148","volume":"52","author":"SS Giri","year":"2016","unstructured":"Giri SS, Sen SS, Jun JW, Sukumaran V, Park SC. Protective effects of leucine against lipopolysaccharide-induced inflammatory response in Labeo rohita fingerlings. Fish Shellfish Immunol. 2016;52:239\u201347.","journal-title":"Fish Shellfish Immunol"},{"key":"76_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2012.03.026","volume":"1455","author":"XD Wang","year":"2012","unstructured":"Wang XD, Notarangelo FM, Wang JZ, Schwarcz R. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice. Brain Res. 2012;1455:1\u20139.","journal-title":"Brain Res"},{"key":"76_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2014.08.007","volume":"44","author":"WA Banks","year":"2015","unstructured":"Banks WA. The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav Immun. 2015;44:1\u20138.","journal-title":"Brain Behav Immun"},{"key":"76_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1046\/j.1471-4159.2002.00955.x","volume":"82","author":"T Kita","year":"2002","unstructured":"Kita T, Morrison PF, Heyes MP, Markey S. Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L\u2010kynurenine and quinolinic acid pools in brain. J Neurochem. 2002;82:258\u201368.","journal-title":"J Neurochem"},{"key":"76_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","volume":"10","author":"CJ Lynch","year":"2014","unstructured":"Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol. 2014;10:723\u201336.","journal-title":"Nat Rev Endocrinol"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0076-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0076-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0076-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T16:58:10Z","timestamp":1684601890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-018-0076-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,9]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1038\/s41380-018-0076-7","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,9]]},"assertion":[{"value":"12 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"R.D. has received honoraria from the Danone Nutricia Research, France, that are not related to the work presented in this article. The remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}